CYP2D6 Genotype and Tamoxifen Response for Breast Cancer: A Systematic Review and Meta-Analysis
Figure 2
Meta-analysis pooled estimates from treatment-only analysis of the association of any CYP2D6 reduced function alleles vs. none with individual outcomes.
Footnotes: Non-fatal events included breast cancer outcomes that were not fatal.